Raymond James & Associates’s Accelerate Diagnostics AXDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,700
Closed -$13.8K 3802
2023
Q2
$13.8K Sell
1,700
-50
-3% -$375 ﹤0.01% 3795
2023
Q1
$12.2K Hold
1,750
﹤0.01% 3831
2022
Q4
$12.4K Hold
1,750
﹤0.01% 3837
2022
Q3
$27K Buy
+1,750
New +$29K ﹤0.01% 3768
2018
Q3
Sell
-1,056
Closed -$235K 3643
2018
Q2
$235K Sell
1,056
-2,808
-73% -$628K ﹤0.01% 3164
2018
Q1
$883K Buy
3,864
+35
+0.9% +$9.19K ﹤0.01% 2219
2017
Q4
$1M Buy
3,829
+1,625
+74% +$381K ﹤0.01% 2127
2017
Q3
$495K Buy
2,204
+478
+28% +$117K ﹤0.01% 2497
2017
Q2
$472K Buy
1,726
+198
+13% +$53.7K ﹤0.01% 2454
2017
Q1
$370K Buy
1,528
+334
+28% +$76.3K ﹤0.01% 2562
2016
Q4
$248K Buy
+1,194
New +$284K ﹤0.01% 2759

Other funds holding AXDX